Cargando…
COVID-19 vaccines in pregnancy
COVID-19 caused by SARS-CoV-2 coronavirus has been associated with severe illness in pregnant women. Furthermore, COVID-19 during pregnancy is associated with adverse fetal outcomes including preterm labor. Pregnant women were largely excluded from initial clinical trials investigating the safety an...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061132/ https://www.ncbi.nlm.nih.gov/pubmed/35610123 http://dx.doi.org/10.1016/j.molmed.2022.04.012 |
_version_ | 1784698662339739648 |
---|---|
author | Nunes, Marta C. Madhi, Shabir A. |
author_facet | Nunes, Marta C. Madhi, Shabir A. |
author_sort | Nunes, Marta C. |
collection | PubMed |
description | COVID-19 caused by SARS-CoV-2 coronavirus has been associated with severe illness in pregnant women. Furthermore, COVID-19 during pregnancy is associated with adverse fetal outcomes including preterm labor. Pregnant women were largely excluded from initial clinical trials investigating the safety and efficacy of COVID-19 vaccines; however, they have since been included as part of the routine roll-out of these vaccines. This narrative review synthesizes the evidence on the safety, immunogenicity, and effectiveness predominantly of the mRNA COVID-19 vaccines which have been most widely used in pregnant women. |
format | Online Article Text |
id | pubmed-9061132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90611322022-05-03 COVID-19 vaccines in pregnancy Nunes, Marta C. Madhi, Shabir A. Trends Mol Med Review COVID-19 caused by SARS-CoV-2 coronavirus has been associated with severe illness in pregnant women. Furthermore, COVID-19 during pregnancy is associated with adverse fetal outcomes including preterm labor. Pregnant women were largely excluded from initial clinical trials investigating the safety and efficacy of COVID-19 vaccines; however, they have since been included as part of the routine roll-out of these vaccines. This narrative review synthesizes the evidence on the safety, immunogenicity, and effectiveness predominantly of the mRNA COVID-19 vaccines which have been most widely used in pregnant women. Elsevier Ltd. 2022-08 2022-05-03 /pmc/articles/PMC9061132/ /pubmed/35610123 http://dx.doi.org/10.1016/j.molmed.2022.04.012 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Nunes, Marta C. Madhi, Shabir A. COVID-19 vaccines in pregnancy |
title | COVID-19 vaccines in pregnancy |
title_full | COVID-19 vaccines in pregnancy |
title_fullStr | COVID-19 vaccines in pregnancy |
title_full_unstemmed | COVID-19 vaccines in pregnancy |
title_short | COVID-19 vaccines in pregnancy |
title_sort | covid-19 vaccines in pregnancy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061132/ https://www.ncbi.nlm.nih.gov/pubmed/35610123 http://dx.doi.org/10.1016/j.molmed.2022.04.012 |
work_keys_str_mv | AT nunesmartac covid19vaccinesinpregnancy AT madhishabira covid19vaccinesinpregnancy |